Human factors engineering for medical devices: European regulation and current issues.

ergonomics human factors medical device risk

Journal

International journal for quality in health care : journal of the International Society for Quality in Health Care
ISSN: 1464-3677
Titre abrégé: Int J Qual Health Care
Pays: England
ID NLM: 9434628

Informations de publication

Date de publication:
12 Jan 2021
Historique:
received: 29 06 2020
revised: 15 08 2020
accepted: 26 08 2020
pubmed: 30 9 2020
medline: 29 7 2021
entrez: 29 9 2020
Statut: ppublish

Résumé

A large proportion of the patient injuries or deaths attributable to medical device (MD) misuse can be eliminated and/or mitigated by adopting an effective human factors and ergonomics (HFE) approach. The implementation of a usability engineering process is now mandatory for MD manufacturers seeking to obtain the European Union's CE Mark. Here, we describe the European Union's HFE regulation and highlight the challenges faced by (i) manufacturers implementing this regulation and (ii) regulatory bodies charged with assessing the compliance of usability files. In Europe, 95% of MD manufacturers are small- and medium-sized enterprises; compliance with the CE Mark regulations is a real challenge to their competitiveness. Levels of knowledge about HFE vary greatly from one regulatory organization to another, which can sometimes lead to very different expectations. We also present the specific use-related risk management approach required by the HFE regulation. Lastly, we focus on the limitations of the HFE regulation for MDs and on future HFE challenges in further reducing and/or eliminating MD use errors. The main challenge is the need to go beyond technology design and the premarket assessment and to look at the postproduction stage; the coupling between an MD and a sociotechnical system can lead to consequences that were not predicted during the design process. This implies the need to consider the emerging properties of technologies in use by involving all the stakeholders.

Identifiants

pubmed: 32991690
pii: 5912963
doi: 10.1093/intqhc/mzaa103
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

31-36

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of International Society for Quality in Health Care. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Sylvia Pelayo (S)

Univ. Lille, CHU Lille, ULR 2694-METRICS: Évaluation des technologies de santé et des pratiques médicales, Institut Coeur Poumon, Bld Professeur J. Leclercg, F-59000, Lille, France.
INSERM CIC-IT 1403, Centre d'Investigation Clinique pour les Innovations Technologiques, Institut Coeur Poumon, Bld Professeur J. Leclercg, F-59000, Lille, France.

Romaric Marcilly (R)

Univ. Lille, CHU Lille, ULR 2694-METRICS: Évaluation des technologies de santé et des pratiques médicales, Institut Coeur Poumon, Bld Professeur J. Leclercg, F-59000, Lille, France.
INSERM CIC-IT 1403, Centre d'Investigation Clinique pour les Innovations Technologiques, Institut Coeur Poumon, Bld Professeur J. Leclercg, F-59000, Lille, France.

Tommaso Bellandi (T)

Regional Centre for Clinical Risk Management and Patient Safety, Via Taddeo Alderotti 26/N, 50100, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH